NCT03452475View on ClinicalTrials.gov

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

PHASE3CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

June 3, 2019

Study Completion Date

June 3, 2019

Conditions
Plasmodium Falciparum
Interventions
DRUG

Arterolane-piperaquine

Arterolane maleate-piperaquine phosphate tablets (37.5 mg/187.5 mg)

DRUG

Arterolane-piperaquine+mefloquine

Arterolane maleate-piperaquine phosphate tablets (37.5 mg/187.5 mg) Mefloquine tablets (250 mg)

DRUG

Artemether-lumefantrine

Artemether-lumefantrine tablets (20 mg/120 mg)

Trial Locations (1)

P.O Box P.O. Box 9

Kilifi County Hospital, Kilifi

All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

University of Oxford

OTHER

NCT03452475 - Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children | Biotech Hunter | Biotech Hunter